ReviewFrontiers in cardiovascular medicine2026
Interpreting heart rate variability in clinical context: a framework for understanding a multidimensional autonomic biomarker.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart rate variability (HRV) is a non-invasive marker of autonomic cardiovascular regulation that reflects beat-to-beat fluctuations in cardiac cycle length. Reduced HRV has been associated with adverse cardiovascular outcomes across multiple disease states, yet its clinical use remains limited by substantial interpretive complexity. Unlike static biomarkers, HRV is highly sensitive to measurement modality, recording duration, circadian timing, behavioral factors, environmental exposures, medications, and comorbidities. Therefore, isolated HRV values cannot be interpreted as direct indicators of autonomic health without careful consideration of context. This review summarizes the physiological basis of HRV, key time-domain, frequency-domain, and nonlinear/complexity metrics, and major acquisition methods, including 24 h electrocardiography (ECG), short-term ECG, chest strap monitors, and wrist-worn devices. It also examines how sleep, physical activity, diet, psychological stress, substance use, age and sex, medications, and cardiovascular or metabolic diseases influence HRV interpretation. We propose a context-aware framework for interpreting HRV as a dynamic physiological signal rather than a standalone diagnostic marker. When appropriately contextualized, HRV may serve as a complementary tool for cardiovascular risk assessment and provide insight into residual risk not fully captured by conventional clinical models.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.